Tolterodine tartrate 2 mg 24HR Extended Release Oral Capsule
RxNorm 855182
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 855182 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: tolterodine tartrate 2 mg 24HR Extended Release Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
24 HR tolterodine tartrate 2 mg Extended Release Oral Capsule
(Atom ID: 6353049)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely tolterodine tartrate 2 mg/1 each prolonged-release oral capsule (clinical drug)
(Atom ID: 12727557)
SYPrescribable
Synonym (SY):
Tolterodine tartrate 2 mg 24 HR Extended Release Oral Capsule
(Atom ID: 6356562)
PSNPrescribable
Prescribable Name (PSN):
Tolterodine tartrate 2 mg 24HR Extended Release Oral Capsule
(Atom ID: 6367159)
PTPrescribable
Designated preferred name (PT):
Tolterodine tartrate 2 mg prolonged-release oral capsule
(Atom ID: 12727990)
Patient Education
Tolterodine
Tolterodine is used treat overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Tolterodine is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles preventing bladder contraction.
[Learn More]
* Please review the disclaimer below.